Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
female (26) 26
adult (19) 19
adolescent (12) 12
index medicus (12) 12
papillomavirus infections - prevention & control (10) 10
cancer (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
young adult (8) 8
immunology (7) 7
cervical cancer (6) 6
male (6) 6
papillomavirus infections - virology (6) 6
research (6) 6
uterine cervical neoplasms - prevention & control (6) 6
cervical intraepithelial neoplasia - prevention & control (5) 5
human papillomavirus (5) 5
infectious diseases (5) 5
medicine, general & internal (5) 5
microbiology (5) 5
obstetrics & gynecology (5) 5
pregnancy (5) 5
risk factors (5) 5
uterine cervical neoplasms - virology (5) 5
vaccines (5) 5
adenocarcinoma (4) 4
animals (4) 4
biology (4) 4
cervical intraepithelial neoplasia - virology (4) 4
clinical medicine (4) 4
double-blind method (4) 4
follow-up studies (4) 4
hong kong (4) 4
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (4) 4
klinisk medicin (4) 4
oncology (4) 4
papillomavirus infections (4) 4
prevention (4) 4
vaccination (4) 4
women (4) 4
abridged index medicus (3) 3
adenocarcinoma - prevention & control (3) 3
alphapapillomavirus - genetics (3) 3
alphapapillomavirus - immunology (3) 3
article (3) 3
basic medicine (3) 3
biochemistry & molecular biology (3) 3
case-control studies (3) 3
cervical intraepithelial neoplasia (3) 3
cervical-cancer (3) 3
chemistry (3) 3
clinical trials (3) 3
clinical-trials (3) 3
condylomata acuminata - prevention & control (3) 3
diagnosis (3) 3
grade cervical lesions (3) 3
health aspects (3) 3
human papillomavirus 16 - immunology (3) 3
immunization (3) 3
lesions (3) 3
medicinska och farmaceutiska grundvetenskaper (3) 3
microbiology in the medical area (3) 3
middle aged (3) 3
mikrobiologi inom det medicinska området (3) 3
papanicolaou test (3) 3
papillomavirus infections - pathology (3) 3
papillomavirus vaccines (3) 3
papillomavirus vaccines - administration & dosage (3) 3
papillomavirus vaccines - immunology (3) 3
particle vaccine (3) 3
risk (3) 3
vaginal smears (3) 3
virus-like particles (3) 3
viruses (3) 3
young-women (3) 3
adenocarcinoma - virology (2) 2
aged (2) 2
alleles (2) 2
alphapapillomavirus - classification (2) 2
antibodies (2) 2
antibodies, viral - biosynthesis (2) 2
biotechnology & applied microbiology (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
carcinoma in situ - prevention & control (2) 2
cervix dysplasia (2) 2
chemistry, multidisciplinary (2) 2
chinese calligraphy (2) 2
computational fluid dynamics (2) 2
computer simulation (2) 2
condylomata acuminata - epidemiology (2) 2
controlled-trial (2) 2
cross-modal interaction (2) 2
demographic aspects (2) 2
development cycle (2) 2
double-blind (2) 2
educational status (2) 2
efficacy (2) 2
epidemiology (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Physics - Circulation Desk (1) 1
Physics - Stacks (1) 1
Richard Charles Lee Canada-Hong Kong - Library use only (1) 1
Robarts - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
by Garland, Suzanne M and Hernandez-Avila, Mauricio and Wheeler, Cosette M and Perez, Gonzalo and Harper, Diane M and Leodolter, Sepp and Tang, Grace W.K and Ferris, Daron G and Steben, Marc and Bryan, Janine and Taddeo, Frank J and Railkar, Radha and Esser, Mark T and Sings, Heather L and Nelson, Micki and Boslego, John and Sattler, Carlos and Barr, Eliav and Koutsky, Laura A and FUTURE I Investigators and Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1928 - 1943
Human papillomaviruses are an important cause of genital warts and cervical cancer. In this large, randomized, placebo-controlled trial, a quadrivalent HPV... 
POPULATION | MEDICINE, GENERAL & INTERNAL | RECURRENT RESPIRATORY PAPILLOMATOSIS | EFFICACY | PARTICLE VACCINE | ADENOCARCINOMA | VULVAR INTRAEPITHELIAL NEOPLASIA | SQUAMOUS-CELL CARCINOMA | CERVICAL-CANCER WORLDWIDE | TYPE-16 | YOUNG-WOMEN | Double-Blind Method | Follow-Up Studies | Humans | Condylomata Acuminata - epidemiology | Genital Neoplasms, Female - prevention & control | Carcinoma in Situ - prevention & control | Genital Neoplasms, Female - epidemiology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Alphapapillomavirus - isolation & purification | DNA, Viral - blood | Adenocarcinoma - prevention & control | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Carcinoma in Situ - epidemiology | Adolescent | Papillomavirus Vaccines - adverse effects | Adult | Female | Prevention | Genital diseases, Female | Disease prevention | Clinical trials | Human papillomavirus | Vaccines | Clinical outcomes | Cervical cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
by Muñoz, Nubia and Kjaer, Susanne K and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Wheeler, Cosette M and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Tay, Eng Hseon and Garcia, Patricía J and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W. K and Ferris, Daron G and Paavonen, Jorma and Steben, Marc and Bosch, F. Xavier and Dillner, Joakim and Huh, Warner K and Joura, Elmar A and Kurman, Robert J and Majewski, Slawomir and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine T and Lupinacci, Lisa C and Giacoletti, Katherine E. D and Sings, Heather L and James, Margaret K and Hesley, Teresa M and Barr, Eliav and Haupt, Richard M and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
by Dillner, Joakim and Kjaer, Susanne K and Wheeler, Cosette M and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Tay, Eng Hseon and García, Patricia and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W.K and Ferris, Daron G and Paavonen, Jorma and Lehtinen, Matti and Steben, Marc and Bosch, F. Xavier and Joura, Elmar A and Majewski, Slawomir and Muñoz, Nubia and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine T and Maansson, Roger and Lu, Shuang and Vuocolo, Scott and Hesley, Teresa M and Barr, Eliav and Haupt, Richard and Future I II Study Grp and FUTURE I/II Study Group and The FUTURE I/II Study Group and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Clinical trials | Human papillomavirus | Vaccines | Womens health | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions
by Kjaer, Susanne K and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Wheeler, Cosette M and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Eng, Hseon Tay and García, Patricia and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W. K and Ferris, Daron G and Paavonen, Jorma and Lehtinen, Matti and Steben, Marc and Bosch, F. Xavier and Dillner, Joakim and Joura, Elmar A and Majewski, Slawomir and Muñoz, Nubia and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine and Maansson, Roger and Lu, Shuang and Vuocolo, Scott and Hesley, Teresa M and Saah, Alfred and Barr, Eliav and Haupt, Richard M and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Cancer Prevention Research, ISSN 1940-6207, 10/2009, Volume 2, Issue 10, pp. 868 - 878
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through... 
ANTIBODIES | WOMEN | RISK-FACTORS | ONCOLOGY | HPV INFECTION | VIRUS-LIKE PARTICLES | RANDOMIZED CLINICAL-TRIALS | CANCER | WARTS | Papillomavirus Infections - complications | Papillomavirus Vaccines - therapeutic use | Humans | Uterine Cervical Neoplasms - prevention & control | Genital Diseases, Female - prevention & control | Human papillomavirus 6 | Cervical Intraepithelial Neoplasia - virology | Human papillomavirus 18 | Randomized Controlled Trials as Topic | Young Adult | Human papillomavirus 16 | Cancer Vaccines - therapeutic use | Clinical Trials, Phase III as Topic | Multicenter Studies as Topic | Papillomavirus Infections - prevention & control | Human papillomavirus 11 | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Genital Diseases, Female - virology | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
by Darron R. Brown and Susanne K. Kjaer and Kristján Sigurdsson and Ole-Erik Iversen and Mauricio Hernandez-Avila and Cosette M. Wheeler and Gonzalo Perez and Laura A. Koutsky and Eng Hseon Tay and Patricía Garcia and Kevin A. Ault and Suzanne M. Garland and Sepp Leodolter and Sven-Eric Olsson and Grace W. K. Tang and Daron G. Ferris and Jorma Paavonen and Marc Steben and F. Xavier Bosch and Joakim Dillner and Elmar A. Joura and Robert J. Kurman and Slawomir Majewski and Nubia Muñoz and Evan R. Myers and Luisa L. Villa and Frank J. Taddeo and Christine Roberts and Amha Tadesse and Janine Bryan and Lisa C. Lupinacci and Katherine E. D. Giacoletti and Heather L. Sings and Margaret James and Teresa M. Hesley and Eliav Barr and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2009, Volume 199, Issue 7, pp. 926 - 935
Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or... 
Adenocarcinoma | Vaccination | Cervical intraepithelial neoplasia | Placebos | Viruses | Infections | Fees | Lesions | Obstetrics | Cervical cancer | INFECTIOUS DISEASES | METAANALYSIS | EFFICACY | CLASSIFICATION | MICROBIOLOGY | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | CANCER | CLINICAL-TRIALS | DOUBLE-BLIND | YOUNG-WOMEN | GRADE CERVICAL LESIONS | Humans | Uterine Cervical Neoplasms - prevention & control | Alphapapillomavirus - classification | Alphapapillomavirus - immunology | Young Adult | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Adolescent | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines | Cervix dysplasia | Demographic aspects | Physiological aspects | Research | Papillomavirus infections | Risk factors | Oncogenic viruses | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
by Joura, Elmar A and Kjaer, Susanne K and Wheeler, Cosette M and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Tay, Eng Hseon and García, Patricia and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Olsson, Sven-Eric and Tang, Grace W.K and Ferris, Daron G and Paavonen, Jorma and Lehtinen, Matti and Steben, Marc and Bosch, Xavier and Dillner, Joakim and Kurman, Robert J and Majewski, Slawomir and Muñoz, Nubia and Myers, Evan R and Villa, Luisa L and Taddeo, Frank J and Roberts, Christine and Tadesse, Amha and Bryan, Janine and Lupinacci, Lisa C and Giacoletti, Katherine E.D and Lu, Shuang and Vuocolo, Scott and Hesley, Teresa M and Haupt, Richard M and Barr, Eliav and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 52, pp. 6844 - 6851
Abstract The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by humoral immunity. We evaluated the correlation... 
Allergy and Immunology | Humoral immunity | Immune memory | Human Papillomavirus | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | CANCERS | HUMAN-PAPILLOMAVIRUS TYPE-6 | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | IMMUNIZATION | IMMUNOGENICITY | VLP VACCINE | VIRUS-LIKE PARTICLES | GENITAL WARTS | GRADE CERVICAL LESIONS | Human papillomavirus 18 - immunology | Follow-Up Studies | Human papillomavirus 6 - immunology | Humans | Condylomata Acuminata - epidemiology | Human papillomavirus 16 - immunology | Condylomata Acuminata - prevention & control | Papillomavirus Infections - pathology | Young Adult | Antibodies, Viral - analysis | Condylomata Acuminata - immunology | Papillomavirus Infections - immunology | Female | Immunization Schedule | Human papillomavirus 11 - immunology | Vagina - pathology | Antibodies, Viral - biosynthesis | Papanicolaou Test | Vaginal Smears | Reverse Transcriptase Polymerase Chain Reaction | Papillomavirus Infections - prevention & control | Adolescent | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Vulva - pathology | Evaluation | Papillomavirus infections | Vaccines | Medical research | Human papillomavirus | Immunization | Cervical cancer | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Mikrobiologi inom det medicinska området
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
by Cosette M. Wheeler and Susanne K. Kjaer and Kristján Sigurdsson and Ole-Erik Iversen and Mauricio Hernandez-Avila and Gonzalo Perez and Darron R. Brown and Laura A. Koutsky and Eng Hseon Tay and Patricia García and Kevin A. Ault and Suzanne M. Garland and Sepp Leodolter and Sven-Eric Olsson and Grace W. K. Tang and Daron G. Ferris and Jorma Paavonen and Marc Steben and F. Xavier Bosch and Joakim Dillner and Elmar A. Joura and Robert J. Kurman and Slawomir Majewski and Nubia Muñoz and Evan R. Myers and Luisa L. Villa and Frank J. Taddeo and Christine Roberts and Amha Tadesse and Janine Bryan and Lisa C. Lupinacci and Katherine E. D. Giacoletti and Margaret James and Scott Vuocolo and Teresa M. Hesley and Eliav Barr and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2009, Volume 199, Issue 7, pp. 936 - 944
Background. We evaluated the impact of a quadrivalent human papillomavirus (HPV) vaccine on infection and cervical disease related to 10 nonvaccine HPV types... 
Adenocarcinoma | Vaccination | Cervical intraepithelial neoplasia | Placebos | Viruses | Infections | Fees | Lesions | Epidemiology | Cervical cancer | ANTIBODIES | DIAGNOSIS | INFECTIOUS DISEASES | VAGINAL INTRAEPITHELIAL NEOPLASIA | PREVENTION | MICROBIOLOGY | CERVICAL-CANCER | COMPETING RISKS | IMMUNOLOGY | RANDOMIZED CLINICAL-TRIALS | LESIONS | GENITAL WARTS | EPITOPES | Humans | Uterine Cervical Neoplasms - prevention & control | Alphapapillomavirus - classification | Alphapapillomavirus - immunology | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Young Adult | Adenocarcinoma - prevention & control | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines | Cervix dysplasia | Demographic aspects | Research | Health aspects | Papillomavirus infections | Risk factors | Oncogenic viruses | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
by Olsson, Sven-Eric and Kjaer, Susanne K and Sigurdsson, Kristján and Iversen, Ole-Erik and Hernandez-Avila, Mauricio and Wheeler, Cosette M and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Hseon Tay, Eng and García, Patricia and Ault, Kevin A and Garland, Suzanne M and Leodolter, Sepp and Tang, Grace W.K and Ferris, Daron G and Paavonen, Jorma and Lehtinen, Jorma and Steben, Marc and Bosch, F. Xavier and Dillner, Joakim and Joura, Elmar and Majewski, Slawomir and Muñoz, Nubia and Myers, Evan R and Villa, Luisa L and Klinisk mikrobiologi, Malmö and Clinical Microbiology, Malmö and Lund University and Lunds universitet
Human Vaccines, ISSN 1554-8600, 10/2009, Volume 5, Issue 10, pp. 696 - 704
Objective In the quadrivalent (types 6/11/16/18) HPV vaccine (GARDASIL®/SILGARD®) clinical program, 73% of women aged 16-26 were naïve to all vaccine HPV... 
Vaccine | Cervical cancer | HPV | CONTROLLED-TRIAL | vaccine | HUMAN-PAPILLOMAVIRUS TYPE-16 | PARTICLE VACCINE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IMMUNOLOGY | cervical cancer | YOUNG-WOMEN | CANCER | Cervix Uteri - virology | Follow-Up Studies | Humans | Papillomavirus Infections - epidemiology | Vulva - virology | Antibodies, Viral - blood | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Papillomavirus Infections - pathology | Young Adult | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - adverse effects | Adult | Cervix Uteri - pathology | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - immunology | Vulva - pathology | Cervix Uteri - cytology | Placebos - administration & dosage | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Mikrobiologi inom det medicinska området
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women
by Zhong, Linda L.D and Tong, Yao and Tang, Grace W.K and Zhang, Zhang Jin and Choi, Wai Ki and Cheng, Kin Lok and Sze, Stephen C.W and Wai, Kun and Liu, Qing and Yu, Ben X.B
Menopause, ISSN 1072-3714, 07/2013, Volume 20, Issue 7, pp. 767 - 776
OBJECTIVEThe aim of this study is to investigate the effectiveness and safety of a Chinese herbal formula, Er-Xian decoction (EXD), in the treatment of... 
Hot flushes | Chinese herbal medicine | Er-Xian decoction | Menopause | Quality of life | PLACEBO | HORMONE-THERAPY | VASOMOTOR SYMPTOMS | BLACK COHOSH | RISK | ALTERNATIVE MEDICINE | COMPLEMENTARY | OBSTETRICS & GYNECOLOGY | QUALITY-OF-LIFE | ESTROGEN PLUS PROGESTIN | HOT FLASHES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The first pilot study of expanded newborn screening for inborn errors of metabolism and survey of related knowledge and opinions of health care professionals in Hong Kong
by Mak, Chloe M and Law, Eric C. Y and Lee, Hencher H. C and Siu, W.K and Chow, K.M and Au Yeung, Sidney K. C and Ngan, Hextan Y. S and Tse, Niko K. C and Kwong, N.S and Chan, Godfrey C. F and Lee, K.W and Chan, W.P and Wong, S.F and Tang, Mary H. Y and Kan, Anita S. Y and Hui, Amelia P. W and So, P.L and Shek, C.C and Lee, Robert S. Y and Wong, K.Y and Yau, Eric K. C and Poon, K.H and Siu, Sylvia and Poon, Grace W. K and Kwok, Anne M. K and Ng, Judy W. Y and Yim, Vera C. S and Ma, Grace G. Y and Chu, C.H and Tong, T.Y and Chong, Y.K and Chen, Sammy P. L and Ching, C.K and Chan, Angel O. K and Tam, Sidney and Lau, Ruth L. K and Ng, W.F and Lee, K.C and Chan, Albert Y. W and Lam, C.W and Chemical Pathology Laboratory, Department of Pathology, Princess Margaret Hospital, Kwai Chung, Hong Kong
Hong Kong Medical Journal, ISSN 1024-2708, 06/2018, Volume 24, Issue 3, pp. 226 - 237
Introduction: Newborn screening is important for early diagnosis and effective treatment of inborn errors of metabolism (IEM). In response to a 2008 coroners'... 
MEDICINE, GENERAL & INTERNAL | ACYLCARNITINE | SPECTRUM | TANDEM MASS-SPECTROMETRY | CHINA | ATTITUDES | Prospective Studies | Hong Kong | Humans | Male | Metabolism, Inborn Errors - therapy | Neonatal Screening - methods | Health Knowledge, Attitudes, Practice | Metabolism, Inborn Errors - diagnosis | Pilot Projects | Health Personnel | Female | Surveys and Questionnaires | Early Diagnosis | Infant, Newborn | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine
by Ault, Kevin A and Joura, Elmar A and Kjaer, Susanne K and Iversen, Ole‐Erik and Wheeler, Cosette M and Perez, Gonzalo and Brown, Darron R and Koutsky, Laura A and Garland, Suzanne M and Olsson, Sven‐Eric and Tang, Grace W.K and Ferris, Daron G and Paavonen, Jorma and Steben, Marc and Bosch, F. Xavier and Majewski, Slawomir and Muñoz, Nubia and Sings, Heather L and Harkins, Kathy and Rutkowski, Mary Anne and Haupt, Richard M and Garner, Elizabeth I.O and FUTURE I II Study Grp and FUTURE I and II Study Group and for the FUTURE I and II Study Group
International Journal of Cancer, ISSN 0020-7136, 03/2011, Volume 128, Issue 6, pp. 1344 - 1353
The primary objective of this report is to describe the detection of adenocarcinoma in situ (AIS) and associated human papillomavirus (HPV) type distribution... 
human papillomavirus (HPV) | adenocarcinoma | vaccine | AIS | natural history | in situ | adenocarcinoma in situ (AIS) | UNITED-STATES | PROPHYLACTIC EFFICACY | RISK | CANCER | HPV | WOMEN | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | NETHERLANDS | GRADE CERVICAL LESIONS | INCIDENCE TRENDS | Cervical Intraepithelial Neoplasia - pathology | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Humans | Uterine Cervical Neoplasms - pathology | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Papillomavirus Infections - pathology | Young Adult | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Colposcopy | Double-Blind Method | Papanicolaou Test | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomaviridae - isolation & purification | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - prevention & control | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | DNA, Viral - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Continuing professional development - A surrogate for recertification?
by Tang, Grace W.K
Annals of the Academy of Medicine Singapore, ISSN 0304-4602, 11/2004, Volume 33, Issue 6, pp. 711 - 714
Medical practitioners are certified as competent when they graduate from medical schools. They are certified as competent specialists after they have completed... 
Continuous medical education | Assessment | assessment | MEDICINE, GENERAL & INTERNAL | continuous medical education | Education, Medical, Continuing | Certification
Journal Article
Details down arrow
13. Full Text Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines
by Suzanne M. Garland and Marc Steben and Mauricio Hernandez-Avila and Laura A. Koutsky and Cosette M. Wheeler and Gonzalo Perez and Diane M. Harper and Sepp Leodolter and Grace W. K. Tang and Daron G. Ferris and Mark T. Esser and Scott C. Vuocolo and Micki Nelson and Radha Railkar and Carlos Sattler and Eliav Barr and on behalf of the 012 Study Investigators and 012 Study Investigators and on behalf of the 012 Study Investigators
Clinical and Vaccine Immunology, ISSN 1556-6811, 06/2007, Volume 14, Issue 6, pp. 792 - 795
Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
INFECTIOUS DISEASES | MICROBIOLOGY | CERVICAL-CANCER | IMMUNOLOGY | Antibodies, Viral - biosynthesis | Papillomavirus Vaccines - classification | Antibody Formation - immunology | Double-Blind Method | Papillomavirus Infections - prevention & control | Humans | Adolescent | Adult | Female | Papillomavirus Vaccines - immunology | Human papillomavirus 16 - immunology | Papillomavirus Vaccines - administration & dosage | Vaccine Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights